Bio Simulation Technology - Global Market Outlook (2015-2022)

Bio Simulation Technology - Global Market Outlook (2015-2022)

  • Published: April 2016
  • ID: SMRC15664

According to Stratistics MRC, the Bio Simulation Technology Market is accounted at $1.01 billion in 2015 and is projected to reach $2.99 billion by 2022 growing at a CAGR of 16.6% from 2015 to 2022. Reduction in the cost of drug discovery and development and risk of failure of drug molecule are some of the factors driving the market growth. Furthermore, R&D investments in biotechnology and pharmaceutical industries, growth in the biologics and biosimilars markets, increased use of personalized medicines, technological advancements and periodic product upgradation are the key factors vitalizing the market growth. However, lack of standardization, high R&D costs associated with development of biosimulation software and lack of skilled professionals are some of the major restraints hampering the market growth. Industrial bioprocessing, nutraceuticals, agri-food production and biosimulation in the defence will provide opportunities for market growth over the forecast period.

Pharmaceutical and biotechnology companies segment is valued to account largest share across the global market. North America is anticipated to command the largest share and Europe is expected to register the highest growth due to increasing government funding and the large number of pharmaceuticals and biotechnology companies in this region.

Some of the key players in this market include Certara USA Inc., Simulation Plus Inc., Dassault Systèmes SA, Schrödinger Inc., Advanced Chemistry Development Inc., Chemical Computing Group Inc., Entelos Holding Corporation, Genedata Ag, Physiomics PLC,  Rhenovia Pharma Ltd., Insilico biosciences, Archimedes, Insilico biotechnology, Accelrys, LeadScope and Compugen.

Application Covered:
• Application In Drug Development
o Clinical Trials
o Preclinical Testing
• In Patient Validation
• Application In Drug Discovery
o Target Validation
o Target Identification
o Lead Identification/Discovery
o Lead Optimization

Product Covered:
• Software
o Toxicity Prediction Software
o Molecular Modeling and Simulation Software
o Trial Design Software
o PK/PD Modeling and Simulation Software
o Pbpk Modeling and Simulation Software
o Other Software
• Services
o External/Contract Services
o In-House Services

End user Covered:
• Regulatory Authorities
• Academic and Government Research Institutes
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain 
o Rest of Europe     
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific   
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary     
       
2 Preface
      
 2.1 Abstract     
 2.2 Stake Holders    
 2.3 Research Scope    
 2.4 Research Methodology   
  2.4.1 Data Mining   
  2.4.2 Data Analysis   
  2.4.3 Data Validation   
  2.4.4 Research Approach   
 2.5 Research Sources    
  2.5.1 Primary Research Sources  
  2.5.2 Secondary Research Sources  
  2.5.3 Assumptions   
       
3 Market Trend Analysis    
 3.1 Introduction    
 3.2 Drivers     
 3.3 Restraints    
 3.4 Opportunities    
 3.5 Threats     
 3.6 Regulatory Guidelines   
 3.7 Product Analysis    
 3.8 Application Analysis   
 3.9 Emerging Markets    
       
4 Porters Five Force Analysis    
 4.1 Bargaining power of suppliers   
 4.2 Bargaining power of buyers   
 4.3 Threat of substitutes   
 4.4 Threat of new entrants   
 4.5 Competitive rivalry    
       
5 Global Bio Simulation Technology Market, By Application  
 5.1 Introduction    
 5.2 Application In Drug Development  
  5.2.1 Clinical Trials    
   5.2.1.1 Phase I Clinical Trial  
   5.2.1.2 Phase Ii Clinical Trial  
   5.2.1.3 Phase Iii Clinical Trial  
  5.2.2 Preclinical Testing   
   5.2.2.1 PK/PD   
   5.2.2.2 ADME/TOX  
 5.3 In Patient Validation    
 5.4 Application In Drug Discovery    
  5.4.1 Target Validation    
   5.4.1.1 Molecular Modeling  
  5.4.2 Target Identification   
   5.4.2.1 Protein Structure Prediction  
  5.4.3 Lead Identification/Discovery   
   5.4.3.1 De Novo Design   
  5.4.4 Lead Optimization    
   5.4.4.1 Qsar (Quantitative Structure–Activity Relationship) Models
       
6 Global Bio Simulation Technology Market, By Product  
 6.1 Introduction    
 6.2 Software      
  6.2.1 Toxicity Prediction Software  
  6.2.2 Molecular Modeling and Simulation Software
  6.2.3 Trial Design Software  
  6.2.4 PK/PD Modeling and Simulation Software
  6.2.5 Pbpk Modeling and Simulation Software 
  6.2.6 Other Software   
 6.3 Services     
  6.3.1 External/Contract Services  
  6.3.2 In-House Services   
       
7 Global Bio Simulation Technology Market, By End user 
 7.1 Introduction    
 7.2 Regulatory Authorities   
 7.3 Academic and Government Research Institutes  
 7.4 Pharmaceutical and Biotechnology Companies 
 7.5 Contract Research Organizations   
       
8 Global Bio Simulation Technology  Market, By Geography 
 8.1 North America    
  8.1.1 US    
  8.1.2 Canada    
  8.1.3 Mexico    
 8.2 Europe     
  8.2.1 Germany    
  8.2.2 France    
  8.2.3 Italy    
  8.2.4 UK    
  8.2.5 Spain    
  8.2.6 Rest of Europe   
 8.3 Asia Pacific    
  8.3.1 Japan    
  8.3.2 China    
  8.3.3 India    
  8.3.4 Australia    
  8.3.5 New Zealand   
  8.3.6 Rest of Asia Pacific   
 8.4 Rest of the World    
  8.4.1 Middle East   
  8.4.2 Brazil    
  8.4.3 Argentina   
  8.4.4 South Africa   
  8.4.5 Egypt    
       
9 Key Developments     
 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
 9.2 Acquisitions & Mergers   
 9.3 New Product Launch   
 9.4 Expansions    
 9.5 Other Key Strategies   
       
10 Company Profiling     
 10.1 Certara USA, Inc.     
 10.2 Simulation Plus Inc.    
 10.3 Dassault Systèmes SA    
 10.4 Schrödinger Inc.     
 10.5 Advanced Chemistry Development, Inc.   
 10.6 Chemical Computing Group, Inc.   
 10.7 Entelos Holding Corporation    
 10.8 Genedata Ag     
 10.9 Physiomics PLC     
 10.10 Rhenovia Pharma Ltd.    
 10.11 Insilico biosciences    
 10.12 Archimedes    
 10.13 Insilico biotechnology   
 10.14 Accelrys     
 10.15 LeadScope    
 10.16 Compugen 


List of Tables      
1 Global Bio Simulation Technology Market Outlook, By Region (2015-2022) ($MN)
2 Global Bio Simulation Technology Market Outlook, By Application (2015-2022) ($MN)
3 Global Bio Simulation Technology Market Outlook, By Application In Drug Development (2015-2022) ($MN)
4 Global Bio Simulation Technology Market Outlook, By Clinical Trials  (2015-2022) ($MN)
5 Global Bio Simulation Technology Market Outlook, By Preclinical Testing (2015-2022) ($MN)
6 Global Bio Simulation Technology Market Outlook, By In Patient Validation  (2015-2022) ($MN)
7 Global Bio Simulation Technology Market Outlook, By Application In Drug Discovery  (2015-2022) ($MN)
8 Global Bio Simulation Technology Market Outlook, By Target Validation  (2015-2022) ($MN)
9 Global Bio Simulation Technology Market Outlook, By Target Identification  (2015-2022) ($MN)
10 Global Bio Simulation Technology Market Outlook, By Lead Identification/Discovery  (2015-2022) ($MN)
11 Global Bio Simulation Technology Market Outlook, By Lead Optimization  (2015-2022) ($MN)
12 Global Bio Simulation Technology Market Outlook, By Product  (2015-2022) ($MN)
13 Global Bio Simulation Technology Market Outlook, By Software (2015-2022) ($MN)
14 Global Bio Simulation Technology Market Outlook, By Toxicity Prediction Software (2015-2022) ($MN)
15 Global Bio Simulation Technology Market Outlook, By Molecular Modeling and Simulation Software (2015-2022) ($MN)
16 Global Bio Simulation Technology Market Outlook, By Trial Design Software (2015-2022) ($MN)
17 Global Bio Simulation Technology Market Outlook, By PK/PD Modeling and Simulation Software (2015-2022) ($MN)
18 Global Bio Simulation Technology Market Outlook, By Pbpk Modeling and Simulation Software (2015-2022) ($MN)
19 Global Bio Simulation Technology Market Outlook, By Other Software (2015-2022) ($MN)
20 Global Bio Simulation Technology Market Outlook, By Services (2015-2022) ($MN)
21 Global Bio Simulation Technology Market Outlook, By External/Contract Services (2015-2022) ($MN)
22 Global Bio Simulation Technology Market Outlook, By In-House Services (2015-2022) ($MN)
23 Global Bio Simulation Technology Market Outlook, By End user (2015-2022) ($MN)
24 Global Bio Simulation Technology Market Outlook, By Regulatory Authorities (2015-2022) ($MN)
25 Global Bio Simulation Technology Market Outlook, By Academic and Government Research Institutes  (2015-2022) ($MN)
26 Global Bio Simulation Technology Market Outlook, By Pharmaceutical and Biotechnology Companies (2015-2022) ($MN)
27 Global Bio Simulation Technology Market Outlook, By Contract Research Organizations  (2015-2022) ($MN)
28 North America Bio Simulation Technology Market Outlook, By Application (2015-2022) ($MN)
29 North America Bio Simulation Technology Market Outlook, By Application In Drug Development (2015-2022) ($MN)
30 North America Bio Simulation Technology Market Outlook, By Clinical Trials  (2015-2022) ($MN)
31 North America Bio Simulation Technology Market Outlook, By Preclinical Testing (2015-2022) ($MN)
32 North America Bio Simulation Technology Market Outlook, By In Patient Validation  (2015-2022) ($MN)
33 North America Bio Simulation Technology Market Outlook, By Application In Drug Discovery  (2015-2022) ($MN)
34 North America Bio Simulation Technology Market Outlook, By Target Validation  (2015-2022) ($MN)
35 North America Bio Simulation Technology Market Outlook, By Target Identification  (2015-2022) ($MN)
36 North America Bio Simulation Technology Market Outlook, By Lead Identification/Discovery  (2015-2022) ($MN)
37 North America Bio Simulation Technology Market Outlook, By Lead Optimization  (2015-2022) ($MN)
38 North America Bio Simulation Technology Market Outlook, By Product  (2015-2022) ($MN)
39 North America Bio Simulation Technology Market Outlook, By Software (2015-2022) ($MN)
40 North America Bio Simulation Technology Market Outlook, By Toxicity Prediction Software (2015-2022) ($MN)
41 North America Bio Simulation Technology Market Outlook, By Molecular Modeling and Simulation Software (2015-2022) ($MN)
42 North America Bio Simulation Technology Market Outlook, By Trial Design Software (2015-2022) ($MN)
43 North America Bio Simulation Technology Market Outlook, By PK/PD Modeling and Simulation Software (2015-2022) ($MN)
44 North America Bio Simulation Technology Market Outlook, By Pbpk Modeling and Simulation Software (2015-2022) ($MN)
45 North America Bio Simulation Technology Market Outlook, By Other Software (2015-2022) ($MN)
46 North America Bio Simulation Technology Market Outlook, By Services (2015-2022) ($MN)
47 North America Bio Simulation Technology Market Outlook, By External/Contract Services (2015-2022) ($MN)
48 North America Bio Simulation Technology Market Outlook, By In-House Services (2015-2022) ($MN)
49 North America Bio Simulation Technology Market Outlook, By End user (2015-2022) ($MN)
50 North America Bio Simulation Technology Market Outlook, By Regulatory Authorities (2015-2022) ($MN)
51 North America Bio Simulation Technology Market Outlook, By Academic and Government Research Institutes  (2015-2022) ($MN)
52 North America Bio Simulation Technology Market Outlook, By Pharmaceutical and Biotechnology Companies (2015-2022) ($MN)
53 North America Bio Simulation Technology Market Outlook, By Contract Research Organizations  (2015-2022) ($MN)
54 Europe Bio Simulation Technology Market Outlook, By Application (2015-2022) ($MN)
55 Europe Bio Simulation Technology Market Outlook, By Application In Drug Development (2015-2022) ($MN)
56 Europe Bio Simulation Technology Market Outlook, By Clinical Trials  (2015-2022) ($MN)
57 Europe Bio Simulation Technology Market Outlook, By Preclinical Testing (2015-2022) ($MN)
58 Europe Bio Simulation Technology Market Outlook, By In Patient Validation  (2015-2022) ($MN)
59 Europe Bio Simulation Technology Market Outlook, By Application In Drug Discovery  (2015-2022) ($MN)
60 Europe Bio Simulation Technology Market Outlook, By Target Validation  (2015-2022) ($MN)
61 Europe Bio Simulation Technology Market Outlook, By Target Identification  (2015-2022) ($MN)
62 Europe Bio Simulation Technology Market Outlook, By Lead Identification/Discovery  (2015-2022) ($MN)
63 Europe Bio Simulation Technology Market Outlook, By Lead Optimization  (2015-2022) ($MN)
64 Europe Bio Simulation Technology Market Outlook, By Product  (2015-2022) ($MN)
65 Europe Bio Simulation Technology Market Outlook, By Software (2015-2022) ($MN)
66 Europe Bio Simulation Technology Market Outlook, By Toxicity Prediction Software (2015-2022) ($MN)
67 Europe Bio Simulation Technology Market Outlook, By Molecular Modeling and Simulation Software (2015-2022) ($MN)
68 Europe Bio Simulation Technology Market Outlook, By Trial Design Software (2015-2022) ($MN)
69 Europe Bio Simulation Technology Market Outlook, By PK/PD Modeling and Simulation Software (2015-2022) ($MN)
70 Europe Bio Simulation Technology Market Outlook, By Pbpk Modeling and Simulation Software (2015-2022) ($MN)
71 Europe Bio Simulation Technology Market Outlook, By Other Software (2015-2022) ($MN)
72 Europe Bio Simulation Technology Market Outlook, By Services (2015-2022) ($MN)
73 Europe Bio Simulation Technology Market Outlook, By External/Contract Services (2015-2022) ($MN)
74 Europe Bio Simulation Technology Market Outlook, By In-House Services (2015-2022) ($MN)
75 Europe Bio Simulation Technology Market Outlook, By End user (2015-2022) ($MN)
76 Europe Bio Simulation Technology Market Outlook, By Regulatory Authorities (2015-2022) ($MN)
77 Europe Bio Simulation Technology Market Outlook, By Academic and Government Research Institutes  (2015-2022) ($MN)
78 Europe Bio Simulation Technology Market Outlook, By Pharmaceutical and Biotechnology Companies (2015-2022) ($MN)
79 Europe Bio Simulation Technology Market Outlook, By Contract Research Organizations  (2015-2022) ($MN)
80 Asia pacific Bio Simulation Technology Market Outlook, By Application (2015-2022) ($MN)
81 Asia pacific Bio Simulation Technology Market Outlook, By Application In Drug Development (2015-2022) ($MN)
82 Asia pacific Bio Simulation Technology Market Outlook, By Clinical Trials  (2015-2022) ($MN)
83 Asia pacific Bio Simulation Technology Market Outlook, By Preclinical Testing (2015-2022) ($MN)
84 Asia pacific Bio Simulation Technology Market Outlook, By In Patient Validation  (2015-2022) ($MN)
85 Asia pacific Bio Simulation Technology Market Outlook, By Application In Drug Discovery  (2015-2022) ($MN)
86 Asia pacific Bio Simulation Technology Market Outlook, By Target Validation  (2015-2022) ($MN)
87 Asia pacific Bio Simulation Technology Market Outlook, By Target Identification  (2015-2022) ($MN)
88 Asia pacific Bio Simulation Technology Market Outlook, By Lead Identification/Discovery  (2015-2022) ($MN)
89 Asia pacific Bio Simulation Technology Market Outlook, By Lead Optimization  (2015-2022) ($MN)
90 Asia pacific Bio Simulation Technology Market Outlook, By Product  (2015-2022) ($MN)
91 Asia pacific Bio Simulation Technology Market Outlook, By Software (2015-2022) ($MN)
92 Asia pacific Bio Simulation Technology Market Outlook, By Toxicity Prediction Software (2015-2022) ($MN)
93 Asia pacific Bio Simulation Technology Market Outlook, By Molecular Modeling and Simulation Software (2015-2022) ($MN)
94 Asia pacific Bio Simulation Technology Market Outlook, By Trial Design Software (2015-2022) ($MN)
95 Asia pacific Bio Simulation Technology Market Outlook, By PK/PD Modeling and Simulation Software (2015-2022) ($MN)
96 Asia pacific Bio Simulation Technology Market Outlook, By Pbpk Modeling and Simulation Software (2015-2022) ($MN)
97 Asia pacific Bio Simulation Technology Market Outlook, By Other Software (2015-2022) ($MN)
98 Asia pacific Bio Simulation Technology Market Outlook, By Services (2015-2022) ($MN)
99 Asia pacific Bio Simulation Technology Market Outlook, By External/Contract Services (2015-2022) ($MN)
100 Asia pacific Bio Simulation Technology Market Outlook, By In-House Services (2015-2022) ($MN)
101 Asia pacific Bio Simulation Technology Market Outlook, By End user (2015-2022) ($MN)
102 Asia pacific Bio Simulation Technology Market Outlook, By Regulatory Authorities (2015-2022) ($MN)
103 Asia pacific Bio Simulation Technology Market Outlook, By Academic and Government Research Institutes  (2015-2022) ($MN)
104 Asia pacific Bio Simulation Technology Market Outlook, By Pharmaceutical and Biotechnology Companies (2015-2022) ($MN)
105 Asia pacific Bio Simulation Technology Market Outlook, By Contract Research Organizations  (2015-2022) ($MN)
106 Rest of the World Bio Simulation Technology Market Outlook, By Application (2015-2022) ($MN)
107 Rest of the World Bio Simulation Technology Market Outlook, By Application In Drug Development (2015-2022) ($MN)
108 Rest of the World Bio Simulation Technology Market Outlook, By Clinical Trials  (2015-2022) ($MN)
109 Rest of the World Bio Simulation Technology Market Outlook, By Preclinical Testing (2015-2022) ($MN)
110 Rest of the World Bio Simulation Technology Market Outlook, By In Patient Validation  (2015-2022) ($MN)
111 Rest of the World Bio Simulation Technology Market Outlook, By Application In Drug Discovery  (2015-2022) ($MN)
112 Rest of the World Bio Simulation Technology Market Outlook, By Target Validation  (2015-2022) ($MN)
113 Rest of the World Bio Simulation Technology Market Outlook, By Target Identification  (2015-2022) ($MN)
114 Rest of the World Bio Simulation Technology Market Outlook, By Lead Identification/Discovery  (2015-2022) ($MN)
115 Rest of the World Bio Simulation Technology Market Outlook, By Lead Optimization  (2015-2022) ($MN)
116 Rest of the World Bio Simulation Technology Market Outlook, By Product  (2015-2022) ($MN)
117 Rest of the World Bio Simulation Technology Market Outlook, By Software (2015-2022) ($MN)
118 Rest of the World Bio Simulation Technology Market Outlook, By Toxicity Prediction Software (2015-2022) ($MN)
119 Rest of the World Bio Simulation Technology Market Outlook, By Molecular Modeling and Simulation Software (2015-2022) ($MN)
120 Rest of the World Bio Simulation Technology Market Outlook, By Trial Design Software (2015-2022) ($MN)
121 Rest of the World Bio Simulation Technology Market Outlook, By PK/PD Modeling and Simulation Software (2015-2022) ($MN)
122 Rest of the World Bio Simulation Technology Market Outlook, By Pbpk Modeling and Simulation Software (2015-2022) ($MN)
123 Rest of the World Bio Simulation Technology Market Outlook, By Other Software (2015-2022) ($MN)
124 Rest of the World Bio Simulation Technology Market Outlook, By Services (2015-2022) ($MN)
125 Rest of the World Bio Simulation Technology Market Outlook, By External/Contract Services (2015-2022) ($MN)
126 Rest of the World Bio Simulation Technology Market Outlook, By In-House Services (2015-2022) ($MN)
127 Rest of the World Bio Simulation Technology Market Outlook, By End user (2015-2022) ($MN)
128 Rest of the World Bio Simulation Technology Market Outlook, By Regulatory Authorities (2015-2022) ($MN)
129 Rest of the World Bio Simulation Technology Market Outlook, By Academic and Government Research Institutes  (2015-2022) ($MN)
130 Rest of the World Bio Simulation Technology Market Outlook, By Pharmaceutical and Biotechnology Companies (2015-2022) ($MN)
131 Rest of the World Bio Simulation Technology Market Outlook, By Contract Research Organizations  (2015-2022) ($MN)

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials